1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
ADVERTISEMENT
- Molecular formula
- C17H27N3O
- CAS Number
- .
- IUPAC Name
- 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
- Molecular Weight
- 315.42g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2200g/cm3
- Appearance
- might change slightly due to environmental factors such as exposure to air or light.
- Synonyms
- emedastine
Identification
Interesting facts
Interesting Facts about 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
This compound, known for its intricate structure, presents several points of interest for researchers in the fields of chemistry and pharmacology. Here are some notable aspects:
- Diverse Applications: Compounds of this nature may exhibit activities that can be leveraged in medicinal chemistry, particularly as potential therapeutic agents targeting various conditions.
- Structural Complexity: The presence of a benzimidazole moiety, along with a diazepan ring, contributes to the structural diversity, which is essential for the development of new pharmacophores.
- Potential for Active Compounds: The ethoxyethyl group may influence solubility and bioavailability, key factors in drug design, as it could enhance the compound's interactions with biological membranes.
- Bioactivity Studies: Research into benzodiazepine derivatives suggests that this compound could possess significant biological activities, necessitating further study into its pharmacodynamics and pharmacokinetics.
- Innovative Research Frontier: Investigating the interaction of such compounds with cellular systems opens pathways for discovering novel treatments, particularly in the realm of neuropharmacology.
In the ever-evolving world of drug development, compounds like 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole remind us that the intersection of chemical structure and biological activity is ripe with potential. As we study these connections further, we may uncover groundbreaking solutions to complex health challenges.